Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
译名:生物化学与生物物理学报-疾病的分子基础
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
5-10
2026
影响因子区间
141天
平台估算
58%
2025
中国作者发文占比
—
收费
期刊简介:BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.
【译文】BBA分子疾病基础探讨疾病过程的生化与分子遗传学,以及人类疾病模型。该期刊涵盖衰老、癌症、代谢性、神经性和免疫性疾病的各个方面。特别鼓励使用动物模型阐明这些条件中的生化与机制洞察力的稿件。稿件应强调疾病途径的潜在机制,并为这些疾病的理解和/或治疗提供新的贡献。高度描述性和方法开发提交可能在没有全面审查的情况下被拒绝。强烈反对向BBA-分子疾病基础提交未邀请的评论,任何此类未邀请的评论都应附有封面信,概述考虑该评论的令人信服的理由。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |